Cornucopia Express is a probiotic superfood designed for dogs and cats. This innovative food helps protect pets from diseases and is believed to extend their lifespan by up to 50%.
Currently, Cornucopia Express is available for purchase on Dr. Geoffrey’s official shop website and at his clinic.
Company Name | Cornucopia Express | |
Founder | Dr. Geoffrey Broderick | |
Founded | 2000 | |
Product | Probiotic Superfoods for Dogs and Cats | |
Asked For | $300k for 15% equity | |
Final Deal | No Deals | |
Shark | No Sharks | |
Episode (Shark Tank USA) | S1 E9 | |
Air Date | Oct 13th, 2009 | |
Business Status | In Business | |
Website | Visit Website | |
Headquarters | Huntington Station, New York, USA | |
Lifetime Worth (Sales) | $2.5M *estimated | |
Buy and Watch | Buy Now | Amazon Prime |
Another Shark Tank Pitch
Who Is The Founder Of Cornucopia Express?
The founder and CEO of Cornucopia Express is Dr. Geoffrey Broderick. He operates an animal clinic in Huntington Station, New York, which is run by his family; his wife is a nurse, and his daughter also works there.
How Was The Shark Tank Pitch of Cornucopia Express?
Geoffrey and Kristina, a father-daughter duo, entered Shark Tank seeking $300,000 for 15% equity in their company, Cornucopia Express. Geoffrey claims that this product can extend pets’ lives by 50%, and he also mentioned that it is safe for human consumption.
During the presentation, Kevin O’Leary tasted the food and remarked that it didn’t taste bad. Daymond John inquired about the possibility of patenting the product, but Geoffrey explained that this would be difficult because it would require disclosing too much information.
However, Geoffrey did not have any scientific proof to back up his claim of a 50% lifespan extension for pets. Robert Herjavec expressed concerns about whether the product could cure cancer or other diseases, leading him to drop out of the deal.
Kevin Harrington emphasized the need for documentation and clinical studies before the product could be sold in stores, which prompted him to decline the investment. Barbara Corcoran also stated that the lack of proof was a dealbreaker for her.
In the end, both Geoffrey and Kristina left Shark Tank without any investment.
Sharks Offers list!
Sharks | Offers |
---|---|
Barbara Corcoran | No Offer |
Kevin O’Leary | No Offer |
Robert Herjavec | No Offer |
Daymond John | No Offer |
Kevin Harrington | No Offer |
Founder’s (Countered) | No Counter |
Final Deals | No Deals |
Cornucopia Express Shark Tank Update
Cornucopia Express did not secure a deal in Shark Tank, as all the Sharks declined to invest. The primary reason for their refusal was Geoffrey’s inability to provide scientific proof supporting the claim that their product could extend the life of dogs and pets by 50%.
Currently, the product is available at Broderick’s Huntington Station Animal Clinic. Due to the lack of scientific validation, it is not sold in retail stores but can be purchased through online platforms.
As of March 2024, the company’s lifetime sales are estimated at $2.5 million, and it remains operational.
Despite not securing investment on Shark Tank, the exposure provided significant free promotion for both the product and the clinic. It is likely that this visibility attracted many visitors to Geoffrey’s Animal Clinic in Huntington Station, potentially boosting their revenue.
What Is Cornucopia Express’s Net Worth?
Cornucopia Express has an estimated net worth of $0.5 million. All the Sharks declined to invest in the company due to the lack of scientific proof supporting its claims. Nevertheless, Dr. Geoffrey is likely to continue prescribing this pet food to pet owners for their animals.
Annual Revenue by Years
Note: This report is based on our research and data so far. In this, we are only estimating the annual revenue.
Years | Annual Revenue |
2000-24 | $2.5M *estimated |
Funding Reports to Date!
Years | Funding Amount | Investor |
N/A | N/A | N/A |
The company is based in Huntington Station, New York, United States.
Yes, Cornucopia Express is still in business as of March 2024.